A study by US-based experts has suggested that Africans suffering from malaria may be getting sub-standard treatment.Researchers from the Pharmacopeia group found that between 26% and 44% of anti-malaria drugs in Uganda, Senegal and Madagascar were of poor quality.
The group, conducting the study for the World Health Organization, said low-grade drugs were being used in both public and private health practices.
Some 90% of malaria deaths in the world occur in Africa.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment